This is not the most recent version of the article. View current version (9 SEP 2014)

Intervention Protocol

Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease

  1. Edward K Teo1,
  2. Lesley Leong1,
  3. Sai Navya Purchuri1,
  4. Hugh House1,
  5. Kathleen Lockhart1,
  6. Jennifer Pushparajah1,
  7. Allan W Cripps2,
  8. Mieke L van Driel3,4,5,*

Editorial Group: Cochrane Acute Respiratory Infections Group

Published Online: 15 AUG 2012

DOI: 10.1002/14651858.CD010010


How to Cite

Teo EK, Leong L, Purchuri SN, House H, Lockhart K, Pushparajah J, Cripps AW, van Driel ML. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 8. Art. No.: CD010010. DOI: 10.1002/14651858.CD010010.

Author Information

  1. 1

    Bond University, Faculty of Health Sciences and Medicine, Gold Coast, Qld, Australia

  2. 2

    Griffith University, Griffith Health, Gold Coast, QLD, Australia

  3. 3

    The University of Queensland, Discipline of General Practice, School of Medicine, Brisbane, Queensland, Australia

  4. 4

    Bond University, Centre for Research in Evidence-Based Practice, Gold Coast, QLD, Australia

  5. 5

    Ghent University, Department of General Practice and Primary Health Care, Ghent, Belgium

*Mieke L van Driel, m.vandriel@uq.edu.au. mieke.vandriel@ugent.be.

Publication History

  1. Publication Status: New
  2. Published Online: 15 AUG 2012

SEARCH

This is not the most recent version of the article. View current version (09 SEP 2014)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

  1. To assess the effectiveness of an oral whole-cell nontypeable H. influenzae (NTHi) vaccine in protecting against recurrent episodes of acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease (COPD).
  2. To assess the effectiveness of NTHi vaccine in reducing NTHi colonising the respiratory tract during recurrent episodes of acute exacerbations of COPD.